Zoetis Inc.
ZTSNYSEHealthcare● Active
$78.11
$-1.33(-1.67%)
Market Cap$32.7B
P/E Ratio—
52W High$171.52
52W Low$72.38
Zoetis Inc. (ZTS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ZTS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$1.53
Est. $1.60 · -4.4%
Revenue
$2.26B
Est. $2.30B · -1.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
ZTS reports quarterly as a NYSE-listed Drug Manufacturers - General company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $1.85 | — | — | — | $2.51B | — |
| ▼ Q2 FY2026 | May 7, 2026 | $1.60 | $1.53 | -4.4% | $2.26B | $2.30B | -1.7% |
| ▲ Q1 FY2026 | Feb 12, 2026 | $1.40 | $1.48 | +5.7% | $2.39B | $2.36B | +1.1% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $1.62 | $1.70 | +4.9% | $2.40B | $2.41B | -0.4% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $1.62 | $1.76 | +8.6% | $2.46B | $2.41B | +2.1% |
| ▲ Q2 FY2025 | May 6, 2025 | $1.41 | $1.48 | +5.0% | $2.22B | $2.19B | +1.4% |
| ▲ Q1 FY2025 | Feb 13, 2025 | $1.37 | $1.40 | +2.2% | $2.32B | $2.30B | +0.9% |
| ▲ Q4 FY2024 | Nov 4, 2024 | $1.46 | $1.58 | +8.2% | $2.39B | $2.29B | +4.3% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$1.85
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
$1.53
EPS Est.
$1.60
EPS Surpr.
-4.4%
Revenue
$2.26B
Q1 FY2026
Feb 12, 2026Beat
EPS Actual
$1.48
EPS Est.
$1.40
EPS Surpr.
+5.7%
Revenue
$2.39B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$1.70
EPS Est.
$1.62
EPS Surpr.
+4.9%
Revenue
$2.40B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$1.76
EPS Est.
$1.62
EPS Surpr.
+8.6%
Revenue
$2.46B
Q2 FY2025
May 6, 2025Beat
EPS Actual
$1.48
EPS Est.
$1.41
EPS Surpr.
+5.0%
Revenue
$2.22B
Q1 FY2025
Feb 13, 2025Beat
EPS Actual
$1.40
EPS Est.
$1.37
EPS Surpr.
+2.2%
Revenue
$2.32B
Q4 FY2024
Nov 4, 2024Beat
EPS Actual
$1.58
EPS Est.
$1.46
EPS Surpr.
+8.2%
Revenue
$2.39B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.80 | $1.84 | $1.88 | 4 |
| Q3 FY2028 | $2.03 | $2.09 | $2.13 | 6 |
| Q2 FY2028 | $2.03 | $2.09 | $2.13 | 4 |
| Q1 FY2028 | $1.64 | $1.69 | $1.73 | 4 |
| Q4 FY2027 | $1.75 | $1.79 | $1.83 | 3 |
| Q3 FY2027 | $1.93 | $1.98 | $2.03 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $2.6B | $2.7B | $2.7B | 3 |
| Q3 FY2028 | $2.6B | $2.7B | $2.7B | 5 |
| Q2 FY2028 | $2.7B | $2.7B | $2.8B | 3 |
| Q1 FY2028 | $2.4B | $2.4B | $2.4B | 3 |
| Q4 FY2027 | $2.5B | $2.6B | $2.6B | 4 |
| Q3 FY2027 | $2.6B | $2.6B | $2.7B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -4.4% | $111.22 | $87.31 | -21.50% |
| ▲ Q1 FY2026 | Feb 12, 2026 | +5.7% | $128.67 | $125.64 | -2.35% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +4.9% | $144.35 | $124.46 | -13.78% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +8.6% | $151.81 | $146.12 | -3.75% |
| ▲ Q2 FY2025 | May 6, 2025 | +5.0% | $158.06 | $149.87 | -5.18% |
| ▲ Q1 FY2025 | Feb 13, 2025 | +2.2% | $173.88 | $164.93 | -5.15% |
| ▲ Q4 FY2024 | Nov 4, 2024 | +8.2% | $181.95 | $175.18 | -3.72% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +4.7% | $174.82 | $185.29 | +5.99% |
Q2 FY2026-21.50%
Report Date
May 7, 2026
EPS Beat/Miss
-4.4%
Price Before
$111.22
Price After
$87.31
Q1 FY2026-2.35%
Report Date
Feb 12, 2026
EPS Beat/Miss
+5.7%
Price Before
$128.67
Price After
$125.64
Q4 FY2025-13.78%
Report Date
Nov 4, 2025
EPS Beat/Miss
+4.9%
Price Before
$144.35
Price After
$124.46
Q3 FY2025-3.75%
Report Date
Aug 5, 2025
EPS Beat/Miss
+8.6%
Price Before
$151.81
Price After
$146.12
Q2 FY2025-5.18%
Report Date
May 6, 2025
EPS Beat/Miss
+5.0%
Price Before
$158.06
Price After
$149.87
Q1 FY2025-5.15%
Report Date
Feb 13, 2025
EPS Beat/Miss
+2.2%
Price Before
$173.88
Price After
$164.93
Q4 FY2024-3.72%
Report Date
Nov 4, 2024
EPS Beat/Miss
+8.2%
Price Before
$181.95
Price After
$175.18
Q3 FY2024+5.99%
Report Date
Aug 6, 2024
EPS Beat/Miss
+4.7%
Price Before
$174.82
Price After
$185.29
Avg Beat Reaction-3.99%
Avg Miss Reaction-21.50%
Beat Rate7 / 8 quarters
Largest Move-21.50% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ZTS ends December
Zoetis Inc. (ZTS) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $1.53 — missing the analyst consensus of $1.60 by -4.4%. The next ZTS earnings date is expected around September 1, 2026.
Each quarter, investors track ZTS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ZTS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ZTS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ZTS earnings · 5 questionsZoetis Inc.'s next earnings report is expected around September 1, 2026. ZTS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ZTS historically reports after market close (AMC).
ZTS earnings datewhen is ZTS earningsZTS next earnings datewhen does ZTS report earningsZTS earnings calendar
▸ Source: FMP · Zoetis Inc. SEC filings · US GAAP · Zoetis Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026